Over 72 weeks, participants without type 2 diabetes achieved the following weight loss results : 5 mg dose: 16.0% average body weight reduction 10 mg dose: 21.4% average body weight reduction 15 mg dose: 22.5% average body weight reduction Placebo: 2.4% average body weight reduction At the highest dose, 92.7% of participants achieved at least 5% weight loss, 84.4% achieved at least 10%, 73.6% achieved at least 15%, 56.1% achieved at least 20%, and 38.7% achieved at least 25% weight loss
Returns & Customer Support Can I return a product
Call us today at 408-850-0176 or visit our contact page to book your appointment
A recent study on hyperfocus across ADHD, autism, and AuDHD found that ADHD-only folks showed less hyperfocus at school than Autistic participants, while AuDHD participants showed the most intense hyperfocus of all three groups except when it came to screen time (Dwyer et al., 2024)
GHK-Cu 100mg GHK-Cu is a research compound studied in tissue signaling, repair models, and immune-related pathways